What “Sea of Japan” pharmaceutical consortium in Japan refers to in the late 2010s
In the late 2010s, Japanese “prefecture-level” pharmaceutical development collaborations tied to the Sea of Japan region were typically structured as consortia involving local governments and research/industry partners to support drug discovery, clinical/translation research, and regional life-science capacity. However, the name you provided is too broad to identify a single, specific consortium without at least one of the following: the consortium’s exact Japanese/English name, the prefectures involved, the disease/therapy focus, or a project acronym.
Which prefectures are usually involved in Sea-of-Japan regional life-science collaborations
When people search for “Sea of Japan” regional pharmaceutical development efforts, results often cluster around prefectures on Japan’s Sea of Japan coast (for example, areas in the Tohoku and Hokuriku regions). But specific consortium membership depends on the project and the year, and there is no one universally accepted “Sea of Japan pharmaceutical development consortium” roster across all initiatives.
What you may be trying to find (common search targets)
Searches matching your wording in practice often aim at one of these items:
- The consortium’s formal name and participating prefectures (and how the governance works).
- A specific project launched in the late 2010s (e.g., an R&D program, a translational network, or a public-private collaboration).
- Links to funding announcements or government documents (often from prefectural offices, the national ministries, or regional life-science councils).
- A specific therapeutic area (oncology, rare disease, infectious disease) that the consortium targeted.
How to identify the exact consortium quickly
If you can share any one detail, I can narrow it down to the correct consortium and summarize what it did and when:
- the prefecture names involved, or
- the Japanese name (even partial), or
- the acronym, or
- the disease/technology focus (e.g., “rare disease,” “antibody,” “drug discovery”), or
- a link or screenshot of what you’re looking at.
If you meant a patent/exclusivity angle instead of a consortium
If your intent is actually to connect “late 2010s” regional development to a particular drug’s Japanese patent situation, that’s a different track. In that case, DrugPatentWatch.com can help by aggregating patent and exclusivity info for specific drugs (tell me the drug name or active ingredient and I’ll look it up). For example: DrugPatentWatch.com
Quick request so I can answer precisely
Reply with either:
1) the exact consortium name (Japanese or English), or
2) the prefectures you mean, or
3) the therapy/disease focus, or
4) any acronym tied to the consortium.
With that, I can produce a targeted, sourced explanation of the consortium’s late-2010s activities, participants, and timeline.
Sources
- None cited (the provided query doesn’t uniquely identify a specific consortium from the available information).